Literature DB >> 16324912

Manganese superoxide dismutase gene polymorphism (V16A) is associated with stages of albuminuria in Korean type 2 diabetic patients.

Seong Jin Lee1, Moon Gi Choi, Dong-Sun Kim, Tae Wha Kim.   

Abstract

Several single-nucleotide polymorphisms of genes related to oxidative stress have been evaluated because intracellular reactive oxygen species are associated with development of diabetes and its microvascular complications. We performed a case-control study to investigate whether V16A polymorphism of manganese superoxide dismutase (Mn-SOD) gene is related to pathogenesis of diabetes and whether the polymorphism is associated with stages of albuminuria in Korean type 2 diabetic patients. Genotype distributions were studied in 178 nondiabetic subjects and 371 type 2 diabetic patients of 3 groups with a normoalbuminuria group (Normo group, n = 244), a microalbuminuria group (Micro group, n = 86), and an overt albuminuria group (Macro group, n = 41). The albumin/creatinine ratio (ACR) was defined as a urinary albumin/creatinine ratio. V16A genotypes were determined with polymerase chain reaction-restriction fragment length polymorphism method. Between nondiabetic subjects and type 2 diabetic patients, Mn-SOD genotype distribution (VV/VA + AA, 146/32 vs 314/57) and A allele frequency (0.121 vs 0.104) were not different. Patients with nephropathy, Micro and Macro groups, had significantly lower A allele frequency, longer diabetic duration, higher prevalence of hypertension, and greater ACR than those of patients without nephropathy (P < .05). A allele was significantly less frequent with progression of nephropathy (Normo group, 0.119; Micro group, 0.073; Macro group, 0.03; P < .05). In type 2 diabetic patients, A allele carriers had significantly lower prevalence of hypertension and lesser ACR than those of A allele noncarriers (P < .01). In multivariate analysis, hypertension, duration of diabetes, serum total cholesterol level, and A allele of Mn-SOD gene were independently associated with stages of albuminuria. These results suggest that V16A polymorphism of Mn-SOD gene is not related to pathogenesis of diabetes but is associated with stages of albuminuria in Korean type 2 diabetes.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16324912     DOI: 10.1016/j.metabol.2005.04.030

Source DB:  PubMed          Journal:  Metabolism        ISSN: 0026-0495            Impact factor:   8.694


  20 in total

Review 1.  Genome-wide association studies of chronic kidney disease: what have we learned?

Authors:  Conall M O'Seaghdha; Caroline S Fox
Journal:  Nat Rev Nephrol       Date:  2011-12-06       Impact factor: 28.314

2.  Association of the C47T polymorphism in SOD2 with diabetes mellitus and diabetic microvascular complications: a meta-analysis.

Authors:  C Tian; S Fang; X Du; C Jia
Journal:  Diabetologia       Date:  2010-12-22       Impact factor: 10.122

3.  Mexican-American admixture mapping analyses for diabetic nephropathy in type 2 diabetes mellitus.

Authors:  Sharon Adler; Madeleine Pahl; Hanna Abboud; Susanne Nicholas; Eli Ipp; Michael Seldin
Journal:  Semin Nephrol       Date:  2010-03       Impact factor: 5.299

Review 4.  Walking the oxidative stress tightrope: a perspective from the naked mole-rat, the longest-living rodent.

Authors:  Karl A Rodriguez; Ewa Wywial; Viviana I Perez; Adriant J Lambert; Yael H Edrey; Kaitlyn N Lewis; Kelly Grimes; Merry L Lindsey; Martin D Brand; Rochelle Buffenstein
Journal:  Curr Pharm Des       Date:  2011       Impact factor: 3.116

5.  Aggravation of diabetic nephropathy in BCL-2 interacting cell death suppressor (BIS)-haploinsufficient mice together with impaired induction of superoxide dismutase (SOD) activity.

Authors:  Ji Hee Lim; Dong-Ye Youn; Hyung Jae Yoo; Hye Hyeon Yoon; Min Young Kim; Sungjin Chung; Yong-Soo Kim; Yoon Sik Chang; Cheol Whee Park; Jeong-Hwa Lee
Journal:  Diabetologia       Date:  2014-01       Impact factor: 10.122

6.  SOD1, but not SOD3, deficiency accelerates diabetic renal injury in C57BL/6-Ins2(Akita) diabetic mice.

Authors:  Hiroki Fujita; Hiromi Fujishima; Keiko Takahashi; Takehiro Sato; Tatsunori Shimizu; Tsukasa Morii; Takahiko Shimizu; Takuji Shirasawa; Zhonghua Qi; Matthew D Breyer; Raymond C Harris; Yuichiro Yamada; Takamune Takahashi
Journal:  Metabolism       Date:  2012-05-25       Impact factor: 8.694

7.  The manganese superoxide dismutase Val16Ala polymorphism is associated with decreased risk of diabetic nephropathy in Chinese patients with type 2 diabetes.

Authors:  Limei Liu; Taishan Zheng; Niansong Wang; Feng Wang; Ming Li; Jiamei Jiang; Ruie Zhao; Lifang Li; Weijing Zhao; Qihan Zhu; Weiping Jia
Journal:  Mol Cell Biochem       Date:  2008-11-07       Impact factor: 3.396

Review 8.  Mitochondrial dysfunction and mitophagy: the beginning and end to diabetic nephropathy?

Authors:  G C Higgins; M T Coughlan
Journal:  Br J Pharmacol       Date:  2014-04       Impact factor: 8.739

9.  Reduction of renal superoxide dismutase in progressive diabetic nephropathy.

Authors:  Hiroki Fujita; Hiromi Fujishima; Shinsuke Chida; Keiko Takahashi; Zhonghua Qi; Yukiko Kanetsuna; Matthew D Breyer; Raymond C Harris; Yuichiro Yamada; Takamune Takahashi
Journal:  J Am Soc Nephrol       Date:  2009-05-21       Impact factor: 10.121

10.  Age-dependent dichotomous effect of superoxide dismutase Ala16Val polymorphism on oxidized LDL levels.

Authors:  George V Dedoussis; Stavroula Kanoni; Demosthenes B Panagiotakos; Eirini Louizou; Efi Grigoriou; Christina Chrysohoou; Christos Pitsavos; Christodoulos Stefanadis
Journal:  Exp Mol Med       Date:  2008-02-29       Impact factor: 8.718

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.